<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garcia-Sobrino R</submitter><funding>Instituto de Salud Carlos III</funding><funding>Ministerio de Ciencia, Innovación y Universidades</funding><funding>Agencia Estatal de Investigación</funding><pagination>1063</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11359487</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(8)</volume><pubmed_abstract>New clinical strategies for treating severe bone and cartilage injuries are required, especially for use in combination with implant procedures. For this purpose, p(VCL-co-HEMA) thermosensitive hydrogels have been activated with icariin-loaded nanoparticles to be used as bone-cell-harvesting platforms. Supercritical CO&lt;sub>2&lt;/sub>-SAS technology has been applied to encapsulate icariin, a small molecule that is involved in osteoblastic differentiation. Thus, physical-chemical analysis, including swelling and transmittance, showed the impact of HEMA groups in hydrogel composition. Moreover, icariin (ICA) release from p(VCL-co-HEMA) platforms, including pVCL@ICA nanoparticles, has been studied to evaluate their efficacy in relevant conditions. Finally, the thermosensitive hydrogels' cell comp</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Osteoblastic Cell Sheet Engineering Using P(VCL-HEMA)-Based Thermosensitive Hydrogels Doped with pVCL@Icariin Nanoparticles Obtained with Supercritical CO&lt;sub>2&lt;/sub>-SAS.</pubmed_title><pmcid>PMC11359487</pmcid><funding_grant_id>RTI2018-096328-B-I00</funding_grant_id><funding_grant_id>PI21/00858</funding_grant_id><funding_grant_id>PDC2022-133446-I00</funding_grant_id><pubmed_authors>Reinecke H</pubmed_authors><pubmed_authors>Elvira C</pubmed_authors><pubmed_authors>Garcia-Crespo A</pubmed_authors><pubmed_authors>Martinez-Campos E</pubmed_authors><pubmed_authors>Rodriguez-Hernandez J</pubmed_authors><pubmed_authors>Casado-Losada I</pubmed_authors><pubmed_authors>Garcia C</pubmed_authors><pubmed_authors>Garcia-Sobrino R</pubmed_authors><pubmed_authors>Caltagirone C</pubmed_authors><pubmed_authors>Gallardo A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Osteoblastic Cell Sheet Engineering Using P(VCL-HEMA)-Based Thermosensitive Hydrogels Doped with pVCL@Icariin Nanoparticles Obtained with Supercritical CO&lt;sub>2&lt;/sub>-SAS.</name><description>New clinical strategies for treating severe bone and cartilage injuries are required, especially for use in combination with implant procedures. For this purpose, p(VCL-co-HEMA) thermosensitive hydrogels have been activated with icariin-loaded nanoparticles to be used as bone-cell-harvesting platforms. Supercritical CO&lt;sub>2&lt;/sub>-SAS technology has been applied to encapsulate icariin, a small molecule that is involved in osteoblastic differentiation. Thus, physical-chemical analysis, including swelling and transmittance, showed the impact of HEMA groups in hydrogel composition. Moreover, icariin (ICA) release from p(VCL-co-HEMA) platforms, including pVCL@ICA nanoparticles, has been studied to evaluate their efficacy in relevant conditions. Finally, the thermosensitive hydrogels' cell comp</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-04T10:38:56.37Z</modification><creation>2024-10-16T14:29:23.649Z</creation></dates><accession>S-EPMC11359487</accession><cross_references><pubmed>39204408</pubmed><doi>10.3390/pharmaceutics16081063</doi></cross_references></HashMap>